OVID:NASDAQ, Ovid Therapeutics Inc.

OVID stock overview

Ovid Therapeutics Inc. (OVID:NASDAQ) closed at $2.47 on October 21, 2026, up 4.66% on the day. The stock trades 20.5% below its 52-week high of $3.11 and 109.3% above its 52-week low of $1.18. Over the past year, it gained 53.4%. Ovid Therapeutics Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$2.47
Day change
+4.66%
Volume
5,003,039
Average volume
1,617,798
Market cap
482M+
52-week range
$1.18 – $3.11
50-day average
$2.60
200-day average
$2.34

Price action over the past year

In 252 trading sessions since October 21, 2025, OVID closed higher on 117 days (46%). Its best day was December 22, 2025 (+21.77%) and its worst was January 28, 2026 (-14.36%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

OVID news

About Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a US-based biopharmaceutical company. The firm is engaged primarily in developing medicines for patients suffering with rare neurological disorders.

Similar stocks

Find more stocks like OVID with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.